AEMD
HealthcareAethlon Medical Inc
$2.38+0.02 (+0.85%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving AEMD Today?
No stock-specific AI insight has been generated for AEMD yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$4M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume20K
Avg Volume (10D)—
Shares Outstanding1.6M
AEMD News
21 articles- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga·May 8, 2026
- AEMD: Hitting Key Milestones as Company Advances Clinical StudyYahoo Finance·Mar 24, 2026
- Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB ReviewYahoo Finance·Mar 24, 2026
- OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, CEO and CFO of Aethlon Medical, and M. Marin, Senior Analyst at Zacks SCRYahoo Finance·Mar 18, 2026
- AEMD: Positive Takeaways From CEO ChatYahoo Finance·Mar 18, 2026
- Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale InitiativesYahoo Finance·Mar 13, 2026
- Life Sciences Virtual Investor Forum Presentations Now Available for Online ViewingYahoo Finance·Mar 13, 2026
- Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic OpportunitiesYahoo Finance·Mar 12, 2026
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12thYahoo Finance·Mar 10, 2026
- Aethlon Medical to Present at the Life Sciences Investor Forum on March 12thYahoo Finance·Mar 6, 2026
- Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live streamYahoo Finance·Feb 24, 2026
- Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026Yahoo Finance·Feb 23, 2026
- AEMD: Advancing Oncology Trial; Seeking to Simplify - Potentially Broaden – Device ApplicationYahoo Finance·Feb 18, 2026
- Aethlon Medical Inc (AEMD) Q3 2026 Earnings Call Highlights: Progress in Oncology Trials and ...Yahoo Finance·Feb 16, 2026
- Aethlon Medical, Inc. Q3 2026 Earnings Call SummaryMoby·Feb 13, 2026
- Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate UpdateYahoo Finance·Feb 12, 2026
- Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026Yahoo Finance·Feb 4, 2026
- Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 MillionYahoo Finance·Dec 5, 2025
- Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAsYahoo Finance·Dec 2, 2025
- AEMD: Can Increased Treatments Extend, Further Improve Positive Patient Responses?Yahoo Finance·Nov 14, 2025
- Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate UpdateYahoo Finance·Nov 12, 2025
All 21 articles loaded
Price Data
Open$2.35
Previous Close$2.36
Day High$2.45
Day Low$2.35
52 Week High—
52 Week Low—
Fundamentals
Market Cap$4M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume20K
Avg Volume (10D)—
Shares Outstanding1.6M
About Aethlon Medical Inc
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
HealthcareSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Company Details
Security TypeStock
ExchangeNASDAQ
Currency—
Round Lot—
SICSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CIK—
Composite FIGI—
Share Class FIGI—